跳至主要内容
临床试验/NCT00799526
NCT00799526Unknown1 期

Transplant of Epithelium Conjunctival Human Autologous Cultivated ex Vivo in Amniotic Membrane for the Treatment of Symblepharon

Federal University of São Paulo0 个研究点目标入组 10 人开始时间: 2008年11月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
10
主要终点
Reconstruction of Ocular surface in patients with symblepharon

研究概览

简要总结

The purpose of this study is to investigate the safety and efficacy of human conjunctival epithelial autologous cultivated ex vivo for reconstruction of the ocular surface in patients with symblepharon.

详细描述

10 patients will be included from 16 to 90 years with presence of symblepharon, what have been already subjected to proceedings of reconstruction of the ocular surface without success and to present conjunctival healthy. In the place of biopsy and after the surgery of the patient one will be applied ointment with antibiotic and corticoid to minimize the inflammatory effects. The fragments will be transported even it laboratory of Molecular Biology of the advanced Centre of Ocular Surface where it will be prosecuted by means of technique sterile under laminating flow. The conjunctival epithelias cells will be put on the amniotic membrane compartments of the plate of culture where the appropriate ways will be added. After 2 weeks the membranes colonized with epithelium conjunctival they will be subjected to the coloration and the cloth will be used for the surgery of reconstruction of the ocular surface. It will be carried out first us an evaluation ophthalmologic complete weekly, 2 months and then fortnightly up to the sixth month post-operative.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with ocular surface disorders, e.g. symblepharon
  • Indications for surgery will be the presence of ocular surface symptoms in the affected eye, loss of visual acuity from visual axis obscuration or irregular astigmatism, or cosmesis.
  • Only one eye of a patient will be eligible for study entry.
  • Patients who are adult males and females who are aged 16 or older, and are considered mentally sound
  • Patients who are willing to undergo long-term follow-up, as outlined in this protocol
  • Patients who have signed an informed consent form that has been approved by the SNEC Ethics Committee.

排除标准

  • Patients less than 16 years of age
  • Patients who are incapable, either by law or of mental state, of giving consent in their own right
  • Patients who are either unable or unwilling to keep scheduled appointments and adhere to the other aspects of the protocol
  • Patients who are pregnant or breastfeeding
  • Patients with a history of drug allergy
  • Patients who have received an investigational drug within 28 days preceding surgery
  • Patients with intraocular pressure over 21 mmHg or history of ocular hypertension or glaucoma
  • Patients who are documented to be steroid responders

结局指标

主要结局

Reconstruction of Ocular surface in patients with symblepharon

时间窗: 6 months

次要结局

  • Re - reconstruction of Ocular surface in patients with symblepharon(6 months)

研究者

发起方
Federal University of São Paulo
申办方类型
Other

相似试验

Transplant of Epithelium Conjunctival Human... | 临床试验